188 related articles for article (PubMed ID: 30334393)
1. Light-activatable cannabinoid prodrug for combined and target-specific photodynamic and cannabinoid therapy.
Ling X; Zhang S; Liu Y; Bai M
J Biomed Opt; 2018 Oct; 23(10):1-9. PubMed ID: 30334393
[TBL] [Abstract][Full Text] [Related]
2. Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.
Li M; Thapa P; Rajaputra P; Bio M; Peer CJ; Figg WD; You Y; Woo S
J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):521-536. PubMed ID: 28913666
[TBL] [Abstract][Full Text] [Related]
3. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy.
Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J
Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic Therapy.
Liu M; Li C
Chempluschem; 2020 May; 85(5):948-957. PubMed ID: 32401421
[TBL] [Abstract][Full Text] [Related]
5. A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy.
Ke MR; Chen SF; Peng XH; Zheng QF; Zheng BY; Yeh CK; Huang JD
Eur J Med Chem; 2017 Feb; 127():200-209. PubMed ID: 28063352
[TBL] [Abstract][Full Text] [Related]
6. Silicon Phthalocyanines Axially Disubstituted with Erlotinib toward Small-Molecular-Target-Based Photodynamic Therapy.
Chen JJ; Huang YZ; Song MR; Zhang ZH; Xue JP
ChemMedChem; 2017 Sep; 12(18):1504-1511. PubMed ID: 28776965
[TBL] [Abstract][Full Text] [Related]
7. A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
Zhou S; Hu X; Xia R; Liu S; Pei Q; Chen G; Xie Z; Jing X
Angew Chem Int Ed Engl; 2020 Dec; 59(51):23198-23205. PubMed ID: 32852145
[TBL] [Abstract][Full Text] [Related]
8. Red light triggered photodynamic-chemo combination therapy using a prodrug caged by photosensitizer.
Xu G; Zhang HX; Li XQ; Yang DC; Liu JY
Eur J Med Chem; 2021 Apr; 215():113251. PubMed ID: 33611187
[TBL] [Abstract][Full Text] [Related]
9. ROS-Activatable siRNA-Engineered Polyplex for NIR-Triggered Synergistic Cancer Treatment.
Zhang M; Weng Y; Cao Z; Guo S; Hu B; Lu M; Guo W; Yang T; Li C; Yang X; Huang Y
ACS Appl Mater Interfaces; 2020 Jul; 12(29):32289-32300. PubMed ID: 32584027
[TBL] [Abstract][Full Text] [Related]
10. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
11. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
[TBL] [Abstract][Full Text] [Related]
12. An epidermal growth factor receptor-targeted and endoplasmic reticulum-localized organic photosensitizer toward photodynamic anticancer therapy.
Zhao X; Ma H; Chen J; Zhang F; Jia X; Xue J
Eur J Med Chem; 2019 Nov; 182():111625. PubMed ID: 31442683
[TBL] [Abstract][Full Text] [Related]
13. Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.
Thapa P; Li M; Bio M; Rajaputra P; Nkepang G; Sun Y; Woo S; You Y
J Med Chem; 2016 Apr; 59(7):3204-14. PubMed ID: 26974508
[TBL] [Abstract][Full Text] [Related]
14. Smart activatable and traceable dual-prodrug for image-guided combination photodynamic and chemo-therapy.
Hu F; Yuan Y; Mao D; Wu W; Liu B
Biomaterials; 2017 Nov; 144():53-59. PubMed ID: 28823843
[TBL] [Abstract][Full Text] [Related]
15. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
[TBL] [Abstract][Full Text] [Related]
16. Multilayer photodynamic therapy for highly effective and safe cancer treatment.
Yang L; Zhang S; Ling X; Shao P; Jia N; Bai M
Acta Biomater; 2017 May; 54():271-280. PubMed ID: 28285077
[TBL] [Abstract][Full Text] [Related]
17. Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer.
Zhang J; Zhang S; Liu Y; Su M; Ling X; Liu F; Ge Y; Bai M
Photodiagnosis Photodyn Ther; 2018 Dec; 24():185-191. PubMed ID: 30240926
[TBL] [Abstract][Full Text] [Related]
18. Light-Activatable Red Blood Cell Membrane-Camouflaged Dimeric Prodrug Nanoparticles for Synergistic Photodynamic/Chemotherapy.
Pei Q; Hu X; Zheng X; Liu S; Li Y; Jing X; Xie Z
ACS Nano; 2018 Feb; 12(2):1630-1641. PubMed ID: 29346736
[TBL] [Abstract][Full Text] [Related]
19. NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy.
Chen H; Zeng X; Tham HP; Phua SZF; Cheng W; Zeng W; Shi H; Mei L; Zhao Y
Angew Chem Int Ed Engl; 2019 Jun; 58(23):7641-7646. PubMed ID: 30980463
[TBL] [Abstract][Full Text] [Related]
20. Traceable Nanocluster-Prodrug Conjugate for Chemo-photodynamic Combinatorial Therapy of Non-small Cell Lung Cancer.
Srinivasulu YG; Mozhi A; Goswami N; Yao Q; Xie J
ACS Appl Bio Mater; 2021 Apr; 4(4):3232-3245. PubMed ID: 35014410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
